Health Condition 1: I809- Phlebitis and thrombophlebitis ofunspecified site
Conditions
Interventions
Intervention1: QPS Heparin: patients will receive QPS Heparin 6- 8 drops TDS up to 72 hr.
Intervention2: QPS Diclofenac: patients will receive QPS Diclofenac 10 spray TDS up to 72 hr.
Control Interv
Sponsors
Dr Vijeta Bajpai
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients of either gender aged 18?60 years, belonging to the American Society of Anesthesiologists (ASA) Class I/II undergoing IV cannulation in the wards for at least 72 hrs will be included in our study. 2 Patients willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1 Pre-existing phlebitis at any other cannulation site 2 Unconscious or comatose patients 3 History of hypersensitivity reaction to heparin or heparin-induced thrombocytopenia 4 Patients receiving irritant IV drugs. 5 Signs of systemic infection, bacteremia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome- 1-To compare the proportion of patients developing no phlebitis (Grade 0) at the end of 72 h of treatment period. 2-To compare proportion of patients developing first signs of infusion phlebitis (Grade I and II) during the 72 h of the treatment period. Timepoint: at the interval of 8 hr upto 72 hr | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary- Efficacy outcome -To compare mean time to reach infusion phlebitis Grade I and II in hours Recording and reporting of adverse events.Timepoint: at the interval of 8 hr upto 72 hr | — |
Countries
India
Contacts
Public ContactDr Vijeta Bajpai
All India Institute of Medical Sciences, Gorakhpur
Outcome results
None listed